influenza
virus
pose
major
threat
public
health
respons
epidem
pandem
result
high
morbid
mortal
worldwid
sever
pandem
spanish
flu
asian
flu
hong
kong
flu
caus
million
death
last
centuri
current
two
therapi
target
viral
protein
neuraminidas
approv
treat
influenza
therefor
novel
viral
host
target
antivir
strategi
block
viral
replic
inhibit
cellular
protein
necessari
viru
life
cycl
urgent
need
context
host
proteas
group
promis
antivir
target
proteolyt
cleavag
precursor
hemagglutinin
subunit
host
proteas
essenti
fusion
ha
endosom
membran
thu
repres
essenti
step
infect
viru
due
potenti
risk
side
effect
applic
broadband
proteas
inhibitor
specif
inhibit
singl
enzym
would
convey
huge
therapeut
benefit
major
influenza
virus
includ
low
pathogen
avian
human
influenza
virus
carri
singl
arginin
r
residu
cleavag
site
cleav
host
trypsinlik
proteas
vitro
studi
cultur
human
respiratori
epitheli
cell
demonstr
involv
sever
membraneassoci
proteas
cell
cultur
studi
identifi
among
other
transmembran
serin
proteas
enzym
abl
cleav
influenza
viru
subtyp
previous
show
delet
knockout
mice
strongli
limit
viral
spread
lung
patholog
influenza
viru
infect
essenti
role
cleavag
activ
viral
spread
also
report
influenza
viru
also
demonstr
delet
slightli
reduc
bodi
weight
loss
mortal
mice
viru
infect
compar
wildtyp
mice
protect
mice
lethal
infect
therefor
like
addit
trypsinlik
proteas
respiratori
tract
abl
cleav
hemagglutinin
influenza
virus
studi
investig
role
context
influenza
viru
replic
pathogenesi
experiment
infect
mice
show
knockout
alon
protect
mice
lethal
influenza
viru
infect
contrast
doubleknockout
mice
show
massiv
reduc
viral
spread
lung
patholog
also
reduc
bodi
weight
loss
mortal
part
work
perform
phd
thesi
work
nora
univers
veterinari
medicin
hannov
germani
experi
mice
approv
extern
committe
accord
nation
guidelin
anim
welfar
law
germani
bgbl
bgbl
protocol
use
experi
review
ethic
committe
approv
landesamt
verbraucherschutz
und
lebensmittelsicherheit
oldenburg
germani
permit
number
mice
maintain
specificpathogenfre
condit
anim
facil
helmholtz
centr
infect
research
hzi
embryon
chicken
egg
purchas
charl
river
laboratori
germani
origin
stock
virus
obtain
stefan
ludwig
univers
variant
peter
univers
freiburg
freiburg
variant
otto
haller
univers
freiburg
ahong
lowvirul
mouseadapt
viru
highvirul
mouseadapt
viru
describ
previous
viru
stock
infect
prepar
infect
embryon
chicken
egg
mutant
mice
gener
use
replac
vector
target
gene
embryon
stem
es
cell
homozyg
knockout
mice
backcross
mice
gener
gener
congen
mice
use
studi
homozyg
mutant
mice
genotyp
pcr
analysi
use
threeprim
strategi
cag
atg
taa
aag
gta
agg
ttc
ctt
gtt
cct
gga
tgt
gac
cat
tgt
allow
us
distinguish
wildtyp
product
knockout
product
allel
doubleknockout
mice
gener
interbreed
homozyg
mice
mice
obtain
janvier
franc
use
control
total
rna
prepar
lung
use
rneasi
midi
kit
qiagen
hilden
germani
follow
manufactur
protocol
cdna
synthes
use
bioscript
system
biolin
gmbh
germani
subsequ
taq
polymeras
redtaq
sigmaaldrich
genespecif
primer
exon
primer
ttg
tgt
gac
ggc
exon
primer
agc
atc
tca
gcg
gtc
use
pcr
amplif
gene
fragment
infect
experi
femal
mice
age
week
anesthet
intraperiton
inject
ketaminexylazin
solut
nacl
ketamin
xylazin
per
g
bodi
weight
infect
perform
intranas
applic
viru
solut
steril
phosphatebuff
salin
pb
subsequ
surviv
bodi
weight
loss
monitor
day
postinfect
pi
addit
mice
found
dead
mice
weight
loss
start
bodi
weight
euthan
record
dead
viral
load
infect
lung
determin
use
mdck
ii
madindarbi
canin
kidney
ii
cell
assay
number
focusform
unit
ffu
describ
earlier
briefli
dilut
seri
homogen
lung
tissu
incub
preseed
mdck
ii
cell
h
dulbecco
modifi
eagl
medium
dmem
contain
nacetyl
trypsin
nat
bovin
serum
albumin
bsa
incub
avicel
overlay
prepar
dmem
contain
nat
bsa
ad
incub
addit
h
subsequ
cell
fix
formalin
viral
particl
detect
antiinfluenza
viru
antibodi
virostat
detect
nonprocess
viral
particl
lung
homogen
dilut
dmem
plu
bsa
without
nat
wash
mdck
ii
cell
homogen
ad
incub
h
afterward
inocul
remov
cell
wash
twice
pb
avicel
overlay
contain
bsa
nat
ad
assay
process
accord
protocol
monitor
hematolog
paramet
heart
punctur
blood
collect
edta
tube
number
lymphocyt
lym
granulocyt
gr
monocyt
mon
blood
determin
immedi
use
vetscan
hematolog
system
abaxi
femal
mice
infect
ffu
influenza
viru
pb
mock
control
day
pi
bronchoalveolar
lavag
bal
fluid
collect
level
granulocyt
colonystimul
factor
gcsf
granulocytemacrophag
colonystimul
factor
gmcsf
gamma
interferon
kc
monocyt
chemoattract
protein
macrophag
inflammatori
protein
rant
vascular
endotheli
growth
factor
vegf
tumor
necrosi
factor
alpha
measur
mous
cytokinechemokin
magnet
bead
panel
merck
millipor
follow
manufactur
instruct
plate
read
luminex
apparatu
lung
prepar
immers
fix
h
buffer
formaldehyd
solut
ph
dehydr
grade
ethanol
seri
embed
paraffin
section
cut
three
evenli
distribut
level
paraffin
block
stain
hematoxylin
eosin
immunohistochem
studi
section
stain
overnight
primari
antibodi
influenza
viru
nucleoprotein
clone
atcc
wessel
germani
subsequ
tissu
section
incub
min
horseradish
peroxidas
hrp
label
goat
antimous
biozol
counterstain
hematoxylin
semiquantit
assess
influenza
viru
antigen
express
lung
perform
report
earlier
follow
minor
modif
alveoli
arbitrarili
chosen
object
field
lung
parenchyma
per
lung
slide
examin
light
microscopi
presenc
influenza
viru
nucleoprotein
without
knowledg
ident
anim
score
anim
present
percentag
posit
field
bronchi
bronchiol
percentag
posit
stain
epithelium
estim
everi
slide
provid
score
per
anim
follow
stain
stain
stain
stain
immunofluoresc
analys
cryosect
air
dri
fix
aceton
rehydr
pb
slide
block
antifcr
purifi
rat
antimous
primari
antibodi
use
rabbit
polyclon
antibodi
bioss
rabbit
antibodi
antikoerperonlin
antibodi
check
appropri
knockout
slide
exclud
potenti
crossreact
stain
slide
wash
pb
dri
mount
neomount
merck
darmstadt
germani
analys
perform
use
zeiss
laser
scan
microscop
oil
immers
object
situ
hybrid
ish
studi
type
alveolar
epitheli
cell
aeci
type
ii
alveolar
epitheli
cell
aecii
formalinfix
paraffinembed
lung
tissu
section
use
quantigen
viewrna
ish
tissu
assay
kit
affymetrix
cleveland
oh
follow
manufactur
instruct
type
sftpc
aecii
type
aeci
quantigen
viewrna
probe
gener
base
affymetrix
probe
set
genbank
access
number
probe
sequenc
follow
type
probe
sftpc
region
type
probe
region
pretreat
perform
min
proteas
digest
perform
min
slide
stain
fast
red
type
probe
type
probe
detect
fast
blue
slide
counterstain
gill
hematoxylin
neg
control
antisens
run
parallel
show
hybrid
signal
shown
type
sftpcneg
neg
control
region
cover
probe
set
type
neg
control
region
cover
probe
set
brightfield
imag
record
use
aperio
scanscop
analyz
aperio
imagescop
softwar
detect
fluoresc
imag
zeiss
laser
scan
microscop
object
use
semiquantit
histopatholog
assess
influenza
virusassoci
inflamm
lung
perform
report
earlier
follow
modif
extent
alveol
score
total
number
alveoli
affect
lung
slide
follow
sever
alveol
bronchiol
bronchiti
score
slide
follow
inflammatori
cell
inflammatori
cell
moder
number
inflammatori
cell
mani
inflammatori
cell
alveoli
bronchiol
bronchi
lung
slide
presenc
alveolar
edema
presenc
alveolar
epitheli
necrosi
report
score
follow
present
present
lung
slide
overal
score
patholog
chang
alveoli
total
score
score
extent
alveol
plu
sever
alveol
plu
presenc
alveolar
edema
plu
presenc
alveolar
epitheli
necrosi
use
slide
examin
without
knowledg
ident
anim
describ
previous
express
type
pneumocyt
bronchial
epitheli
cell
main
target
cell
influenza
virus
addit
proteas
vitro
ha
cleavag
potenti
therefor
examin
express
profil
mous
lung
tissu
perform
situ
hybrid
ish
analys
differenti
type
type
ii
alveolar
epitheli
cell
aeci
aecii
respect
noninfect
mous
lung
shown
fig
round
mostli
cuboid
aecii
detect
express
cell
typespecif
marker
surfactantassoci
protein
c
sftpc
stain
blue
thin
flat
aeci
could
identifi
express
cell
typespecif
marker
aquaporin
stain
red
addit
use
immunohistochem
stain
detect
express
stain
could
observ
cuboid
granular
cell
alveolar
tissu
repres
aecii
fig
well
bronchiolar
epithelium
fig
use
mice
carri
delet
gene
studi
role
influenza
viru
infect
vivo
rtpcr
analysi
knockout
lung
tissu
confirm
absenc
fulllength
transcript
data
shown
protein
detect
knockout
mice
immunohistochem
stain
data
shown
mice
show
normal
reproduct
rate
develop
growth
pattern
obviou
abnorm
phenotyp
wildtyp
well
mice
infect
mouseadapt
viru
wildtyp
mice
lost
weight
infect
compar
kinet
show
similar
surviv
rate
fig
analog
result
obtain
infect
two
addit
viru
variant
data
shown
infect
multibas
mouseadapt
viru
data
shown
infect
ffu
mouseadapt
viru
bodi
weight
loss
surviv
differ
two
mous
strain
fig
also
statist
signific
differ
observ
infect
lower
dose
ffu
viru
fig
measur
viral
load
lung
infect
mice
reveal
equal
viral
load
wildtyp
knockout
mice
day
pi
fig
result
indic
loss
knockout
mice
protect
mice
viru
replic
spread
pathogenesi
infect
influenza
viru
comparison
wildtyp
mice
abl
cleav
hemagglutinin
vitro
express
influenza
viru
target
cell
therefor
gener
doubleknockout
mice
infect
ffu
viru
inde
infect
doublemut
mice
show
delay
significantli
reduc
loss
bodi
weight
compar
wildtyp
mice
singleknockout
mice
fig
furthermor
viral
load
significantli
lower
doubleknockout
mice
wildtyp
mice
infect
ffu
viru
day
pi
fig
addit
rel
weight
wildtyp
lung
increas
consider
day
postinfect
knockout
lung
fig
indic
less
infiltr
immun
cell
accumul
fluid
agreement
observ
rel
number
granulocyt
peripher
blood
increas
higher
level
wildtyp
mice
doubleknockout
mice
infect
viru
fig
repres
indic
sever
influenza
viru
infect
howev
wildtyp
knockout
mice
show
similar
degre
lymphopenia
first
day
pi
follow
increas
lymphocyt
knockout
wildtyp
mice
fig
similar
granulocytosi
observ
strain
day
pi
furthermor
measur
protein
level
inflammatori
chemokin
cytokin
bal
fluid
three
day
infect
increas
level
chemokin
observ
mice
compar
mockinfect
mice
importantli
observ
significantli
less
express
kc
rant
vegf
knockout
mice
wildtyp
mice
fig
detect
level
observ
knockout
sampl
time
point
histopatholog
wildtyp
knockout
mice
develop
multifoc
mild
sever
necrot
suppur
bronchointerstiti
pneumonia
tabl
wildtyp
mice
day
pi
alveolar
septa
multifoc
mildli
thicken
infiltr
neutrophil
alveolar
bronchiolar
bronchial
lumina
contain
scant
moder
amount
inflammatori
exud
consist
viabl
degener
neutrophil
increas
number
alveolar
macrophag
mild
accumul
proteinac
fluid
edema
hemorrhag
multifoc
moder
necrosi
bronchiolar
bronchial
epithelia
around
bronchiol
bronchi
pulmonari
blood
vessel
infiltr
moder
number
viabl
degener
neutrophil
lymphocyt
plasma
cell
macrophag
day
pi
lesion
sever
extend
larger
area
lung
day
pi
consist
sever
infiltr
inflammatori
cell
mild
alveolar
moder
bronchiolar
epitheli
necrosi
intraalveolar
edema
tabl
day
pi
lesion
sever
extend
larger
area
day
pi
also
mild
type
ii
alveolar
epitheli
cell
hyperplasia
knockout
mice
overal
patholog
score
alveoli
compar
wildtyp
mice
day
pi
howev
bronchiolar
damag
less
sever
wildtyp
mice
day
immunohistochemistri
influenza
viru
antigen
present
respiratori
epitheli
cell
stronger
express
nucleu
cytoplasm
wildtyp
mice
day
pi
multifoc
type
ii
alveolar
epitheli
cell
mani
bronchiolar
bronchial
epitheli
cell
express
viru
antigen
fig
c
day
pi
alveolar
cell
posit
fewer
bronchiolar
bronchial
epitheli
cell
posit
day
pi
day
pi
posit
alveolar
epitheli
cell
compar
number
posit
bronchiolar
bronchial
epitheli
cell
compar
day
pi
fig
knockout
mice
fewer
posit
cell
overal
case
wildtyp
mice
fig
f
number
posit
alveolar
epitheli
cell
increas
day
pi
number
bronchiolar
bronchial
epitheli
cell
decreas
day
pi
final
examin
whether
reduc
viral
replic
lung
mutant
mice
also
reflect
reduc
ha
activ
perform
modifi
ffu
assay
lung
homogen
prevent
artifici
ha
cleavag
follow
viral
entri
mdck
ii
cell
addit
exogen
trypsin
homogen
incub
cell
without
addit
proteinas
medium
condit
complet
matur
viru
particl
enter
cell
form
foci
abl
detect
signific
smaller
amount
matur
viru
total
amount
viru
sampl
doubleknockout
mice
fig
contrast
differ
observ
wildtyp
sampl
without
trypsin
treatment
taken
togeth
data
show
mediat
activ
influenza
virus
cleavag
matur
viral
hemagglutinin
progeni
delet
host
factor
result
reduc
viral
replic
spread
pathogenesi
season
influenza
virus
well
newli
emerg
subtyp
pose
major
threat
human
health
influenza
virus
depend
host
cell
factor
cell
entri
replic
identif
host
factor
understand
role
influenza
viru
life
cycl
great
import
develop
novel
therapeut
target
particular
host
proteas
exhibit
trypsinlik
activ
hat
matriptas
mspl
shown
cleav
influenza
viru
monobas
cleavag
site
support
multicycl
viru
replic
cell
cultur
notabl
alter
express
identifi
suscept
marker
sever
influenza
viru
infect
human
hand
trypsinlik
proteas
prostasin
hepsin
activ
ha
upon
coexpress
mammalian
cell
show
previous
requir
cleavag
activ
vivo
mutant
mice
complet
protect
mortal
infect
sever
virus
addit
infect
ffu
viru
also
carri
monobas
cleavag
site
ha
result
less
bodi
weight
loss
lower
mortal
mice
wildtyp
mice
howev
differ
less
pronounc
infect
increas
viru
dose
therefor
investig
whether
proteas
may
involv
cleavag
activ
virus
show
first
time
hemagglutinin
recruit
differ
host
proteas
cleavag
activ
vivo
delet
alon
singleknockout
mice
measur
effect
respect
bodi
weight
loss
surviv
patholog
howev
delet
doubleknockout
mice
significantli
improv
morbid
surviv
viru
infect
nevertheless
mice
still
show
limit
bodi
weight
loss
indic
residu
activ
spread
viral
particl
wildtyp
mice
exhibit
higher
mortal
doubleknockout
mice
show
increas
viral
load
day
pi
addit
wildtyp
mice
exhibit
higher
level
chemokin
higher
lung
weight
day
pi
indic
higher
rate
cellular
infiltr
lung
edema
furthermor
bronchiolar
damag
sever
wildtyp
mice
doubleknockout
mice
day
thu
increas
mortal
rate
wildtyp
mice
like
caus
higher
degre
tissu
destruct
viru
earli
time
point
addit
immunopatholog
result
increas
infiltr
immun
cell
elev
level
inflammatori
chemokin
may
contribut
increas
patholog
reduc
surviv
wildtyp
mice
sever
studi
address
physiolog
role
three
specif
substrat
identifi
ha
influenza
viru
urokinasetyp
plasminogen
activ
plau
epitheli
sodium
channel
increas
express
associ
increas
progress
metastat
potenti
sever
cancer
transcript
detect
gastrointestin
tract
esophagu
stomach
small
intestin
colon
urogenit
tract
kidney
bladder
mous
bronchiolaralveolar
epitheli
cell
human
lung
tissu
nevertheless
vivo
function
protein
still
unclear
recent
studi
show
regul
epitheli
sodium
channel
affect
delet
lung
tissu
express
describ
human
bronchial
epithelium
aecii
alveolar
macrophag
confirm
express
alveolar
region
bronchial
epitheli
cell
murin
lung
show
proteas
coexpress
granular
roughli
cuboid
cell
repres
aecii
studi
influenza
viru
antigen
detect
almost
exclus
aecii
lesser
degre
alveolar
macrophag
coloc
host
proteas
viru
strongli
suggest
proteas
recruit
ha
matur
proteas
cleavag
site
pekqtr
mouseadapt
variant
use
studi
ident
cleavag
site
origin
human
isol
ahong
gener
season
influenza
virus
subtyp
caus
sever
symptom
human
virus
one
may
thu
hypothes
increas
access
ha
two
proteas
allow
effici
replic
virus
may
associ
sever
patholog
proteas
abl
cleav
hemagglutinin
faster
viru
replic
caus
ill
shown
increas
express
lead
sever
outcom
human
diseas
caus
pandem
viru
novel
avian
viru
comparison
amino
acid
sequenc
psiqsr
pekqtr
cleavag
site
show
three
differ
also
see
fig
refer
howev
like
specif
effici
proteas
cleavag
determin
amino
acid
sequenc
cleavag
site
also
overal
tertiari
quaternari
structur
ha
cleavag
site
viru
also
cleav
support
view
consist
amino
acid
eipkgr
quit
differ
cleavag
site
therefor
import
investig
structur
proteas
hemagglutinin
determin
molecular
mechan
ha
cleavag
suscept
effici
note
delet
chang
tropism
viru
infect
mice
consist
observ
proteas
express
cell
type
thu
remov
alon
still
abl
activ
virus
vice
versa
surviv
rate
increas
delet
proteas
due
reduc
viral
load
lung
although
viru
replic
decreas
still
detect
process
ha
protein
viral
spread
patholog
data
conclud
addit
proteas
abl
cleav
activ
hemagglutinin
virus
differ
proteas
shown
activ
virus
vitro
hat
express
mainli
murin
trachea
bronchi
thought
cleav
ha
mainli
upper
region
lower
respiratori
tract
furthermor
kallikreinrel
peptidas
describ
cleav
tryptas
clara
report
cleav
ha
matriptas
cleav
ha
certain
degre
recent
studi
also
report
host
proteas
mspl
capabl
cleav
vitro
summari
vivo
analys
provid
import
insight
involv
host
proteas
influenza
viru
ha
process
studi
suggest
inhibitor
target
would
well
suitabl
block
replic
major
degre
influenza
viru
infect
repres
current
season
subtyp
human
note
howev
result
obtain
mous
model
develop
use
potenti
inhibitor
requir
valid
studi
human
